• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Modern therapy of hematologic malignancies].

作者信息

Trnĕný M

机构信息

I. interní klinika 1. LF UK a VFN, Praha.

出版信息

Cas Lek Cesk. 2001 Nov 22;140(23):711-6.

PMID:11787232
Abstract

Remarkable progress has been done during the last three decades in the therapy of hematological malignancies. It is now possible to cure significant number of patients by chemotherapy, radiotherapy, and stem cell transplantation. However, there is still a large group of patients and situations where our approaches are failing. It is evident that in some circumstance chemotherapy and radiotherapy get close to their limits. A short insight into the group of novel therapeutic methods is given in this review. Such promising methods of treatment include the new chemotherapeutic drugs, new molecules that specifically act on the level molecular mechanisms (STI 571, ATRA, arsenic trioxide, etc.), immunotherapy (monoclonal antibodies, vaccination strategy, exploration of dendritic cells etc.), gene therapy and innovations in stem cell transplantation (graft versus leukemia/lymphoma effect). The future treatment will include combination of standard or intensified chemo/radiotherapy and the new methods, which allow better control of the disease.

摘要

相似文献

1
[Modern therapy of hematologic malignancies].
Cas Lek Cesk. 2001 Nov 22;140(23):711-6.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
Manipulation of the stem cell as a target for hematologic malignancies.将干细胞作为血液系统恶性肿瘤的治疗靶点进行操控。
Semin Oncol. 2000 Oct;27(5):512-23.
4
Newer monoclonal antibodies for hematological malignancies.用于血液系统恶性肿瘤的新型单克隆抗体。
Exp Hematol. 2008 Jul;36(7):755-68. doi: 10.1016/j.exphem.2008.04.018.
5
Hematopoietic stem cell transplant as a platform for tumor immunotherapy.
Curr Opin Mol Ther. 2004 Feb;6(1):48-53.
6
Hematopoietic stem cell transplantation in hematologic malignancy.血液系统恶性肿瘤中的造血干细胞移植
Panminerva Med. 2004 Mar;46(1):61-74.
7
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.低强度预处理方案后的异基因造血干细胞移植:难治性恶性肿瘤患者的一项试点研究。
Cancer. 2002 May 1;94(9):2409-15. doi: 10.1002/cncr.10491.
8
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].非清髓性预处理后的异基因干细胞移植:荷兰乌得勒支大学医学中心治疗的21例血液系统恶性肿瘤高危患者的良好结果
Ned Tijdschr Geneeskd. 2003 Nov 22;147(47):2328-32.
9
Towards immunogene therapy of hematological malignancies.迈向血液系统恶性肿瘤的免疫基因治疗
Exp Hematol. 2006 Mar;34(3):251-63. doi: 10.1016/j.exphem.2005.10.004.
10
Update on non-myeloablative stem cell transplantation for hematologic malignancies.血液系统恶性肿瘤非清髓性干细胞移植的进展
Int J Hematol. 2002 Aug;76 Suppl 1:368-75.